GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Current Deferred Taxes Liabilities

Kimia Biosciences (BOM:530313) Current Deferred Taxes Liabilities : ₹0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Kimia Biosciences's current deferred tax liabilities for the quarter that ended in . 20 was ₹0.00 Mil.

Kimia Biosciences Current Deferred Taxes Liabilities Historical Data

The historical data trend for Kimia Biosciences's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Current Deferred Taxes Liabilities Chart

Kimia Biosciences Annual Data
Trend
Current Deferred Taxes Liabilities

Kimia Biosciences Semi-Annual Data
Current Deferred Taxes Liabilities

Kimia Biosciences Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines